Skip to main content
. 2013 Oct 21;15(1):26–34. doi: 10.4161/cbt.26604

graphic file with name cbt-15-26-g3.jpg

Figure 3. Significantly downregulated genes in the EFNL-treated mammary tumors. Three mammary tumor samples from vehicle-treated and EFNL-treated rats are used to perform apoptosis, angiogenesis, and PI3K/AKT pathway-focused PCR array analyses. The fold difference of downregulated genes in the EFNL-treated group are represented as mean ± SD. P < 0.05 was considered as statistically significant.